跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
芳乐舒 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Recombinant Human Follitropin Prefilled Syringe
Approved
生物制品
Recombinant Human Follitropin Prefilled Syringe
LG Chem, Ltd.
🇨🇳 National Medical Products Administration
Approval Date
Apr 7, 2021
Approval ID
887Ur35R47V
Company
LG Chem, Ltd.
Type
生物制品
Approval Details
Approval Id
887Ur35R47V
Approval Number
国药准字SJ20210006
Generic Name
重组人促卵泡激素注射液
Generic Name En
Recombinant Human Follitropin Prefilled Syringe
Trade Name
芳乐舒
Drug Type
生物制品
Dosage Form
注射剂
Strength
150IU(0.3ml)/支
Reg Date
2021-04-07
Expired Date
2026-04-06
Company Name
LG Chem, Ltd.
Production Company Name
LG Chem, Ltd.
Company Detail Path
/organization/lg-chem-ltd-seoul-south-korea
Production Company Detail Path
/organization/lg-chem-ltd-seoul-south-korea
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 7, 2021
Approval ID
887Ur35R47V
Type
生物制品
Back to NMPA Approvals
